A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra(®)) in Chinese healthy subjects

PURPOSE: QX003S is a biosimilar candidate for the reference tocilizumab, Actemra®. We investigated the tolerance, variability, and pharmacokinetics (PK) of QX003S biosimilar in healthy Chinese male subjects. DESIGN: A randomised, double-blind, two-arm, parallel study was performed to examine the bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong, Li, Xiaojiao, Liu, Jingrui, Li, Cuiyun, Wu, Min, Zhu, Xiaoxue, Sun, Jixuan, Fang, Min, Ding, Yanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919877/
https://www.ncbi.nlm.nih.gov/pubmed/33629921
http://dx.doi.org/10.1080/07853890.2021.1887925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919877/
https://www.ncbi.nlm.nih.gov/pubmed/33629921
http://dx.doi.org/10.1080/07853890.2021.1887925

Ejemplares similares